NCT02398370View on ClinicalTrials.gov

Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of Mild to Moderate ED

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

March 31, 2015

Conditions
Erectile Dysfunction
Interventions
BIOLOGICAL

Placental Matrix-Derived Mesenchymal Stem Cells (PMD-MSCs)

Trial Locations (1)

33076

Z Urology, Coral Springs

All Listed Sponsors
lead

Melissa Marchand

OTHER

NCT02398370 - Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of Mild to Moderate ED | Biotech Hunter | Biotech Hunter